Product Information
NORETHIND-ETH ESTRAD 0.5-2.5 is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.7862 per EA under NDC 68462065629. Its NADAC has been published 562 times since Nov 18, 2015.
FDA first approved this application on Apr 2, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5; .5 ug/1; mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462065629
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ETHINYL ESTRADIOL; NORETHINDRONE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA203038FDA Approved
4/2/2015
TE Code
AB
On Market Since
4/2/2015
Price Statistics
The NADAC for NORETHIND-ETH ESTRAD 0.5-2.5 has been published 562 times since Nov 18, 2015, and over the history we have for it it has declined 73.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7862 per EA |
|---|---|
| All-time high | $3.0722 (Feb 10, 2016) |
| All-time low | $0.6551 (Jun 17, 2026) |
| 52-week high | $1.0935 |
| 52-week low | $0.6551 |
| Median price | $1.4889 |
| Average price | $1.8402 |
| Largest weekly change | +124.6% (Apr 21, 2021) |
| Weeks tracked | 562 |
| Tracking since | Nov 18, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Norethindrone Acetate and Ethinyl Estradiol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NORETHIND-ETH ESTRAD 0.5-2.5?
The current National Average Drug Acquisition Cost (NADAC) for NORETHIND-ETH ESTRAD 0.5-2.5, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.7862 per EA (NDC 68462065629), effective Aug 19, 2026.
How has the price of NORETHIND-ETH ESTRAD 0.5-2.5 changed over time?
Over the history we have for it, the NADAC for NORETHIND-ETH ESTRAD 0.5-2.5 has declined 73.1%. It has been tracked across 562 weekly CMS publications since Nov 18, 2015.
What are the highest and lowest recorded NADAC prices for NORETHIND-ETH ESTRAD 0.5-2.5?
Since Nov 18, 2015, the NADAC for NORETHIND-ETH ESTRAD 0.5-2.5 has ranged from a low of $0.6551 (Jun 17, 2026) to a high of $3.0722 (Feb 10, 2016), with a median of $1.4889 per EA.
Are there cheaper alternatives to NORETHIND-ETH ESTRAD 0.5-2.5?
No other NADAC-published product currently shares the active ingredient and strength of NORETHIND-ETH ESTRAD 0.5-2.5 in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NORETHIND-ETH ESTRAD 0.5-2.5?
NORETHIND-ETH ESTRAD 0.5-2.5 (NDC 68462065629) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.